Primary Recommendation

Craneware - Big beneficiary of Obamacare

November 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in AIM-listed Craneware, which supplies billing and auditing software to help hospitals, have been on a bit of a tear - see chart. The strong share price performance has been driven by powerful underlying fundamentals in the US where the key ‘prop’ has been the introduction of the Affordable Care Act (Obamacare) in the US, which has set the market for this kind of software ablaze.As we describe one of the main tenets of the Act is to ensure patients get seen by doctors early on so that any chronic health issues they might have can be nipped in the bud. The US government is trying to achieve this by making it mandatory for individuals in the US to have their own health insurance policies and this has seen 16m more ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

EMIS - Higher margins than Kainos

NAHL - Shares rocket over £4

Craneware (September 2024)

Craneware - Growing pipeline of opportunities (October 2023)

Craneware (July 2019)

Craneware (August 2018)

Craneware - Two significant new contracts (March 2018)

Craneware - Gain since main profile: 154% (February 2018)

Craneware - Bullet proof business (October 2016)

Craneware (August 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X